Journal article · 2026 · Open access
Artificial Intelligence in Drug Discovery and Development: Current Status, Challenges and Future Prospects
Journal of Pharmacreations · Published 23 April 2026
In brief
“Artificial Intelligence in Drug Discovery and Development: Current Status, Challenges and Future Prospects” is a 2026 journal article by K. Gopika and 2 co-authors, published in Journal of Pharmacreations. OpenAlex counts 0 citations as of 15 November 2026. It is open access: the full text is free to read at Journal of Pharmacreations.
- Citations
- 0
- References
- 23
- Authors
- 3
Abstract
The review article examines the transformative influence of Artificial Intelligence (AI) in redefining the paradigms of drug discovery and pharmaceutical development. It explores how progressive innovations in AI methodologies including Machine Learning (ML), Deep Learning (DL), Natural Language Processing (NLP), Reinforcement Learning (RL), Graph Neural Networks (GNN), and Generative AI are being strategically harnessed to address critical bottlenecks in the drug development continuum. Key areas of focus include target identification, lead molecule exploration, rational drug design, optimization strategies, and clinical trial orchestration. The review highlights AI's potential to revolutionize the pharmaceutical landscape by expediting drug discovery trajectories and curtailing the costs associated with introducing novel therapeutic entities.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Gopika, K., Hasan, S. E., & Alagumanivasagam, G. (2026). Artificial Intelligence in Drug Discovery and Development: Current Status, Challenges and Future Prospects. Journal of Pharmacreations. https://pharmacreations.com/index.php/jpc/article/view/377
MLA 9
Gopika, K., et al. “Artificial Intelligence in Drug Discovery and Development: Current Status, Challenges and Future Prospects.” Journal of Pharmacreations, 2026. https://pharmacreations.com/index.php/jpc/article/view/377.
Chicago
Gopika, K., S. Enamul Hasan, and G. Alagumanivasagam. 2026. “Artificial Intelligence in Drug Discovery and Development: Current Status, Challenges and Future Prospects.” Journal of Pharmacreations. https://pharmacreations.com/index.php/jpc/article/view/377.
Harvard
Gopika, K., Hasan, S. E. and Alagumanivasagam, G. (2026) ‘Artificial Intelligence in Drug Discovery and Development: Current Status, Challenges and Future Prospects’, Journal of Pharmacreations. Available at: https://pharmacreations.com/index.php/jpc/article/view/377.
IEEE
K. Gopika, S. E. Hasan, and G. Alagumanivasagam, “Artificial Intelligence in Drug Discovery and Development: Current Status, Challenges and Future Prospects,” Journal of Pharmacreations, 2026.
BibTeX
@article{gopika2026artificial,
title = {{Artificial Intelligence in Drug Discovery and Development: Current Status, Challenges and Future Prospects}},
author = {Gopika, K. and Hasan, S. Enamul and Alagumanivasagam, G.},
journal = {Journal of Pharmacreations},
year = {2026},
url = {https://pharmacreations.com/index.php/jpc/article/view/377}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- artificial intelligence in drug discovery
- machine learning
- deep learning
- natural language processing
- reinforcement learning
- graph neural networks
- generative AI
- target identification
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Gopika, K., Hasan, S. E., & Alagumanivasagam, G. (2026). Artificial Intelligence in Drug Discovery and Development: Current Status, Challenges and Future Prospects. Journal of Pharmacreations. https://pharmacreations.com/index.php/jpc/article/view/377
How many times has this paper been cited?
0 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Journal of Pharmacreations.
Who wrote this paper?
K. Gopika, S. Enamul Hasan, G. Alagumanivasagam.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.